Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
8/13/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187309628&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 187309628 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 8/13/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 187309628 10.1186/s13058-025-02095-6 187309628 ppf: 1 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer. aug: au: Ravani, Lis Victoria Bagheri, Zahra Brufsky, Adam M. Michellon, Isabella O'Regan, Ruth Lustberg, Maryam Han, Hyo Wang, Ming Wander, Seth A. affil: https://ror.org/036rp1748 Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|